Search Results 381-390 of 1007 for 씨밀레토토

1. A Study of Grapiprant and Pembrolizumab in Patients with Advanced or Progressive MSS Colorectal Cancer - Mayo Clinic

   This study will be conducted in adult participants diagnosed with any form of an advanced or progressive MSS CRC for which 1st and 2nd line standard therapy (at ...

2. A Phase 2 Study Of PRM-151 In Subjects With Myelofibrosis - Mayo Clinic

   PRM-151 is an investigational drug that is being developed for possible use in the treatment of myelofibrosis (MF), a disease in which the bone marrow, which is ...

3. A Study to Explore the Effects of the Measles Virus on Tumor Immunity - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. Phase 3 Study of Optune Concomitant with Temozolomide plus Pembrolizumab in Newly Diagnosed Glioblastoma - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. Publications - Taimur Sher, M.D. - Mayo Clinic

   Amyloidosis and Heart Transplantation in a New Era. Clin Transplant. 2025 Jan; 39(1):e70070. View PubMed; Ailawadhi S, Adu Y, Frank RD, Das S, Hodge DO, ...

6. A Study of GC012F, a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma(MM) - Mayo Clinic

   The purpose of this study is to test GC012F, a CD19/BCMA dual CART-cell therapy, in adult subjects with relapsed/refractory Multiple Myeloma. Participation ...

7. Community Internal Medicine in Florida - Clinical trials

   The primary goal of this study is to establish a database of underrepresented populations who consented to be contacted for biomedical research including ...

8. Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease - Mayo Clinic

   The objective of this study is to determine if using Fuzzy Wale compression stockinett can assist in reducing the healing time and decrease costs in trastibial ...

9. A Study Evaluating the Safety and Effectiveness of UCART Targeting CS1 in Patients with Relapsed/Refractory Multiple Myeloma (MELANI-01) - Mayo Clinic

   The purpose of this study is to evaluate the safety and clinical activity of one infusion of UCARTCS1A (t-cells) and to determine the Maximum Tolerated Dose ( ...

10. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Participation eligibility.